David Rescott
Stock Analyst at Baird
(4.28)
# 467
Out of 4,761 analysts
48
Total ratings
62.79%
Success rate
13.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Maintains: Outperform | $305 → $328 | $291.68 | +12.45% | 25 | Feb 19, 2025 | |
| MDT Medtronic | Maintains: Neutral | $90 → $91 | $89.94 | +1.18% | 4 | Feb 19, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $107 → $109 | $103.16 | +5.66% | 2 | Oct 31, 2024 | |
| LIVN LivaNova | Maintains: Outperform | $66 → $72 | $47.44 | +51.77% | 3 | Oct 31, 2024 | |
| EW Edwards Lifesciences | Maintains: Neutral | $73 → $68 | $73.30 | -7.23% | 3 | Oct 25, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $503 → $565 | $591.79 | -4.53% | 1 | Oct 18, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $90 → $91 | $104.49 | -12.91% | 4 | Jul 25, 2024 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $17.84 | +45.74% | 6 | Dec 22, 2023 |
Penumbra
Feb 19, 2025
Maintains: Outperform
Price Target: $305 → $328
Current: $291.68
Upside: +12.45%
Medtronic
Feb 19, 2025
Maintains: Neutral
Price Target: $90 → $91
Current: $89.94
Upside: +1.18%
Merit Medical Systems
Oct 31, 2024
Maintains: Outperform
Price Target: $107 → $109
Current: $103.16
Upside: +5.66%
LivaNova
Oct 31, 2024
Maintains: Outperform
Price Target: $66 → $72
Current: $47.44
Upside: +51.77%
Edwards Lifesciences
Oct 25, 2024
Maintains: Neutral
Price Target: $73 → $68
Current: $73.30
Upside: -7.23%
Intuitive Surgical
Oct 18, 2024
Maintains: Outperform
Price Target: $503 → $565
Current: $591.79
Upside: -4.53%
Boston Scientific
Jul 25, 2024
Maintains: Outperform
Price Target: $90 → $91
Current: $104.49
Upside: -12.91%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $17.84
Upside: +45.74%